Jeffrey Scott Riley Gain Therapeutics, Inc. (GANX) insider trading activity

GANX Quotes by TradingView

Jeffrey Scott Riley is Director of Gain Therapeutics, Inc.. Currently has a direct ownership of 30,000 shares of GANX, which is worth approximately $51,600. The most recent transaction as insider was on Mar 28, 2024, when has been sold 30,000 shares (Common Stock) at a price of $3.86 per share, resulting in proceeds of $115,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30K
0% 3M change
n/a 12M change
Total Value Held $51,600

Jeffrey Scott Riley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 28 2024
BUY
Open market or private purchase
$115,800 $3.86 p/Share
30,000 Added 50.0%
30,000 Common Stock
JSR

Jeffrey Scott Riley

Director
Bethesda, MD

Track Institutional and Insider Activities on GANX

Follow Gain Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GANX shares.

Notify only if

Insider Trading

Get notified when an Gain Therapeutics, Inc. insider buys or sells GANX shares.

Notify only if

News

Receive news related to Gain Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GANX